Guidance

Appendix E: supporting documents

Appendix E: supporting documents

The supporting documents include:

  • Evidence reviews:

    • Review 1: Prevention of cardiovascular disease at population level (Question 1; phase 1)

    • Review 2: Prevention of cardiovascular disease at population level (Question 1; phase 2)

    • Review 3: Prevention of cardiovascular disease at population level (Question 1; phase 3)

    • Review 4: Barriers to, and facilitators for, multiple risk factor programmes aimed at reducing cardiovascular disease within a given population: a systematic review of qualitative research.

  • Primary research:

    • Review 5: Population and community programmes addressing multiple risk factors to prevent cardiovascular disease: A qualitative study into how and why some programmes are more successful than others.

  • Economic analysis:

    • Review 6: Prevention of cardiovascular disease at population level (Question 1; cost-effectiveness).

  • Economic modelling:

    • Prevention of cardiovascular disease at population level: modelling strategies for primary prevention of cardiovascular disease.

  • Expert reports:

    • Report 1: The effectiveness of physical activity promotion interventions

    • Report 2: Health policy analysis

    • Report 3: Expert testimony on salt and cardiovascular disease

    • Report 4: The relationship between commercial interests and risk of cardiovascular disease

    • Report 5: Regional development of a population-based collaborative CVD prevention strategy: the experience of NHS West Midlands

    • Report 6: NICE guidance on the prevention of CVD at population level: evidence from the Co-operative Group

    • Report 7: Population and community programmes addressing multiple risk factors to prevent cardiovascular disease (CVD): addendum to qualitative study produced by Peninsula Technology Assessment Group for NICE: CVD programme – Heart of Mersey (HoM)

    • Report 8: Expert testimony paper on the independent evaluation of 'have a heart Paisley' phase one (Scotland's national CHD prevention demonstration project)

    • Report 9: Expert testimony on the public health harm caused by industrially produced trans fatty acids and actions to reduce and eliminate them from the food system in the UK

    • Report 10: Prevention of cardiovascular disease at a population level: evidence on interventions to address dietary fats

    • Report 11: CVD risk factors: paradigms and pathways

    • Report 12: CVD prevention in populations: lessons from other countries

    • Report 13: Will CVD prevention widen health inequalities?

    • Report 14: Food manufacturer's perspective.

  • Fieldwork report: Fieldwork on prevention of cardiovascular disease at population level.